Navigation Links
Argus Announces Retail Network Relationship
Date:9/22/2011

KANSAS CITY, Mo., Sept. 22, 2011 /PRNewswire/ -- Argus Health Systems, Inc., a leading transparent pharmacy benefits administrator, today announced an arrangement with Walmart to provide expanded network services. This Preferred Network approach coordinates efforts by Argus and Walmart to provide the lowest prescription benefit cost to Argus customers.

This agreement enables Argus to offer their customers a more cost-effective pharmacy network alternative. Access to care becomes more affordable for the members utilizing this network. Providing quality care at a low cost is a crucial component for member health, since affordable medicine now can prevent costly medical expenses in the future.

"With results based on a cost analysis of pricing currently in effect, we see a potential cost savings to our customers of more than two percent in the Preferred Network over an open network," said Jonathan Boehm, president and CEO, Argus Health Systems. "When using the Preferred Network approach, there is also an additional two percent savings potential, for an estimated total savings of more than four percent."

The Argus and Walmart arrangement can be utilized for commercial, Medicaid, and Medicare networks.

About Argus Health Systems, Inc.

Argus is a leading independent provider of health care information management services supporting commercial, Medicare Part D, and Medicaid through a fully transparent business model. Argus is a wholly-owned subsidiary of DST Systems, Inc. For more information, please visit http://argushealth.com.

The information and comments above may include forward-looking statements respecting DST and its businesses. Such information and comments are based on DST's views as of today, and actual actions or results could differ. There could be a number of factors affecting future actions or results, including those set forth in DST's latest periodic financial report (Form 10-K or 10-Q) filed with the Securities and Exchange Commission. All such factors should be considered in evaluating any forward-looking comment. The Company will not update any forward-looking statements in this press release to reflect future events.


'/>"/>
SOURCE Argus Health Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Intrasphere Technologies to Help Develop and Deliver Global Partner Training for the Oracle(R) Argus Safety Suite Through Oracle PartnerNetwork
2. AAIPharma Services Announces 24/7 Online Compendial Raw Materials Testing
3. Sangamo BioSciences Announces Presentation at the Sixth Annual JMP Securities Healthcare Conference
4. Mylan Announces XELODA® Settlement and License Agreement
5. MedWaves, Incorporated Announces Receipt of Taiwan Food and Drug Administration (TFDA) Certification to Import and Sell Its Patented AveCure™ Microwave Ablation System and Devices
6. Niiki Pharma Announces Positive Interim Data from Ongoing Clinical Trial of Novel Anti-Cancer Agent NKP-1339
7. Ingenuity Announces New Additional MicroRNA Content to Complement First-of-its-Kind MicroRNA Filtering Capability in IPA
8. Cellular Dynamics Announces Commercial Launch of iCell® Endothelial Cells for Vascular-Targeted Drug Discovery
9. Accuray Announces Results for Fourth Quarter and Fiscal Year 2011
10. Watson Pharmaceuticals Announces Approval of Amphastars Generic LOVENOX(R)
11. Marshall Edwards Announces First Patient Dosed in Phase I Clinical Trial of Lead Oncology Drug Candidate ME-143
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)...  Las Vegas ophthalmology practice, Center For Sight, announced ... Dublin ), an implant that shunts ... intraocular pressure in patients with moderate to severe glaucoma. ... glaucoma that can lead to progressive optic nerve damage ... untreated. According to the National Eye Institute, ...
(Date:3/28/2017)... 2017 The U.S. Food and Drug ... adults with moderate-to-severe eczema (atopic dermatitis). Dupixent is ... adequately by topical therapies, or those for whom ... used with or without topical corticosteroids. ... approving new and innovative therapies for patients with ...
(Date:3/28/2017)... , March 28, 2017  "US Cancer Generics ... the various indicators and trend analysis related to ... in mainstream pharmaceutical market in US. The report ... the growth on cancer generics drugs in recent ... saving of billions of dollars for various stake ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... March 28, 2017 , ... ... and services, is proud to announce it has joined the National Association for ... the interests of chronically ill, disabled, and dying Americans of all ages and ...
(Date:3/28/2017)... ... March 28, 2017 , ... Via Oncology, ... the launch of a free, public-facing tool for analyzing the costs of various ... to provide comparative information to patients, providers, insurers and pharmaceutical companies about the ...
(Date:3/28/2017)... ... March 28, 2017 , ... Z-Medica, LLC, a ... Pittsburgh Medical Center (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) to equip ... in association with efforts by the American College of Surgeons, U.S. Department of ...
(Date:3/28/2017)... ... 28, 2017 , ... Usually, the impending arrival of warmer weather means the ... about a double chin, this means more anxiety than elation. The cosmetic dermatology experts ... people, a double chin is undesirable,” Dr. Goldman said, “but it seems doubly so ...
(Date:3/28/2017)... ... March 28, 2017 , ... Calibration, qualification, ... ensuring high-quality results and maintaining GMP and USP compliance. In a new webinar ... with GMP requirements " these requirements are explained. The challenge is to ...
Breaking Medicine News(10 mins):